Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-29

Clinical Trial Update: A Study of Nonoxynol-9 (N-9) and HIV Infection [Phase 3]

View source ↗

Summary

Phase 3 trial update for Nonoxynol-9 (N-9) in HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nonoxynol-9 (Nonoxynol-9)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED